Cargando…
Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study
BACKGROUND: Sacral neuromodulation (SNM) is a minimally invasive fully reversible therapy that was approved in 1997 for overactive bladder syndrome (OAB) refractory to behavior modification and pharmacotherapy. Despite being in use for over two decades, the data on medium to long-term safety and eff...
Autores principales: | Kaaki, Bilal, Gupta, Digant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347151/ https://www.ncbi.nlm.nih.gov/pubmed/32645082 http://dx.doi.org/10.1371/journal.pone.0235961 |
Ejemplares similares
-
Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
por: Trinh, Hamilton, et al.
Publicado: (2019) -
Sleep disturbance changes in women after treatment of refractory overactive bladder with sacral neuromodulation
por: Sanderson, Derrick J., et al.
Publicado: (2020) -
Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder
por: Zhang, Yaoguang, et al.
Publicado: (2021) -
Sacral neuromodulation in overactive bladder: a review and current perspectives
por: Sukhu, Troy, et al.
Publicado: (2016) -
Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance
por: Poole, Ruth Louise, et al.
Publicado: (2021)